Designated Representative: Jason Newland, MD, MEd
Pediatric Infectious Diseases Society (PIDS), Arlington, VA; Designated Representative: Jason Newland, MD, MEd
The Pediatric Infectious Diseases Society (PIDS) is the world’s leading society representing the field of pediatric infectious diseases, with over 1,200 members who are engaged in the prevention, treatment, and cure of infectious diseases. PIDS has nominated Dr. Jason Newland to serve as their designated representative.
Jason Newland is a Professor of Pediatrics at Washington University in St. Louis and the Director of the Antimicrobial Stewardship Program (ASP) at St. Louis Children’s Hospital. Additionally, he leads the BJC Healthcare Systems Infectious Diseases Clinical Expert Council and Antimicrobial Stewardship Collaborative. Prior to arriving at Washington University and BJC Healthcare, he was the medical director of the ASP at Children’s Mercy Hospital in Kansas City. At both Children’s Mercy Hospital and St. Louis Children’s Hospital, he has implemented effective ASPs that have observed significant improvement in antimicrobial use and improvement in patient outcomes.
Dr. Newland is a national and international leader in the field of antimicrobial stewardship. He has served on many important committees at the Centers for Disease Control and Prevention regarding antimicrobial stewardship and how to best accomplish the goals set forth in the National Action Plan for Combating Antibiotic-Resistant Bacteria. He is the Chair of the Pediatric Infectious Diseases Society’s Committee on Antimicrobial Stewardship and has led this group since its inception in 2010. His outstanding work in antimicrobial stewardship led to his invite to the 2015 White House Forum on Antimicrobial Stewardship.
Dr. Newland’s research focuses on improving the use of antibiotics in all healthcare settings and aiding hospitals in developing and evaluating their antimicrobial stewardship programs (ASP). He has authored over 110 peer-reviewed publication in many of the leading journals on this topic. He is most recognized for his establishment of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative, a quality improvement collaborative comprised of over 60 hospitals dedicated to improving the use of antibiotics. The SHARPS Collaborative provides antimicrobial stewardship physicians and pharmacists with numerous resources to aid in improving and evaluating their program. Lastly, Dr. Newland has organized and led the only dedicated Pediatric Antimicrobial Stewardship Conference in the World. This conference began in 2010 as a one day meeting with 30 participants. This meeting has continued to grow annually and has become one of the premiere ASP meetings in the country.